Medication error when switching from warfarin to rivaroxaban leading to spontaneous large ecchymosis of the abdominal and chest wall

Medication error when switching from warfarin to rivaroxaban leading to spontaneous large ecchymosis of the abdominal and chest wall

Non-vitamin K oral anticoagulant (NOAC) therapy may be inappropriate if prescription was incorrect, the patient’s physiological parameters change, or interacting concomitant medications are erroneously added. The aim of this report was to illustrate inappropriate NOAC prescription in a 78-year-old w...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Flavio Egger, Federica Targa, Ivan Unterholzner, Russell P. Grant, Markus Herrmann, Christian J. Wiedermann
Format:	Artykuł
Język:	English
Wydane:	MDPI AG 2016-08-01
Seria:	Clinics and Practice
Hasła przedmiotowe:	Direct oral anticoagulants therapeutic drug monitoring drug safety drug-drug interaction pharmacovigilance anticoagulant reversal
Dostęp online:	https://www.clinicsandpractice.org/index.php/cp/article/view/873

Podobne zapisy

Warfarin interactions: a letter to editor
od: Sayyed Majid Sadrzadeh, i wsp.
Wydane: (2019-10-01)

Case report: Medical cannabis—warfarin drug-drug interaction
od: Tyan F. Thomas, i wsp.
Wydane: (2022-01-01)

Case report on interaction of warfarin with herbal medicine “kadha”
od: Rajendra Kumar Premchand, i wsp.
Wydane: (2021-05-01)

Advances in Monitoring and Reversal Strategies for the Novel Anticoagulants Factor Ⅺ Inhibitors
od: CHEN Yuexiu, YAO Yuanyuan, SUN Dawei, WANG Ying, WU Chaomin, ZHAO Linqian, TANG Zhifeng, ZHANG Fengjiang
Wydane: (2025-01-01)

A rare case of Diffuse Alveolar Hemorrhage (DAH) due to warfarin toxicity
od: Borjian Solmaz, i wsp.
Wydane: (2020-03-01)

Warfarin-Induced Limb Contusion and Haematoma
od: Soumya, i wsp.
Wydane: (2023-04-01)

Warfarin: pharmacological profile and drug interactions with antidepressants
od: Juliana Souto Teles, i wsp.
Wydane: (2012-03-01)

Decrease in Efficacy of Warfarin as a Result of Drug-Drug Interaction (Case Report)
od: N. T. Vatutin, i wsp.
Wydane: (2020-03-01)

Suspected Rivaroxaban-Induced Anaphylaxis Secondary to Ingestion of Rivaroxaban and Nimesulide Without Cross-Reactivity to Dabigatran – A Case Report
od: Gumbis G, i wsp.
Wydane: (2023-10-01)

Applied Nanotechnologies in Anticoagulant Therapy: From Anticoagulants to Coagulation Test Performance of Drug Delivery Systems
od: Yuri B. G. Patriota, i wsp.
Wydane: (2021-05-01)

Possible interaction of warfarin with peppermint herbal tea: a case report
od: Aliasghar Moeinipour, i wsp.
Wydane: (2017-05-01)

The Prevalence and Risks of Inappropriate Combination of Aspirin and Warfarin in Clinical Practice: Results From WARFARIN-TR Study
od: Salih Kılıç, i wsp.
Wydane: (2019-01-01)

Anticoagulation Drug Therapy: A Review
od: Harter, Katherine, i wsp.
Wydane: (2015-01-01)

Warfarin: pharmacological profile and drug interactions with antidepressants
od: Juliana Souto Teles, i wsp.
Wydane: (2012-03-01)

Effects of sodium ferulate for injection on anticoagulation of warfarin in rats in vivo
od: Yue Zhao, i wsp.
Wydane: (2024-02-01)

Atrial Fibrillation Patients Treated With Long‐Term Warfarin Anticoagulation Have Higher Rates of All Dementia Types Compared With Patients Receiving Long‐Term Warfarin for Other Indications
od: T. Jared Bunch, i wsp.
Wydane: (2016-07-01)

Research progress of antithrombotic drugs
od: ZHANG Jie, MA Xuzhou, LI Huihui, WANG Miao
Wydane: (2023-01-01)

Assessing the link between rivaroxaban concentration and the onset of renal impairment in elderly patients: A retrospective observational study
od: Motakatla Usha Rani, i wsp.
Wydane: (2024-06-01)

An Assessment of Osteoporotic Conditions among Users and Non-Users of Warfarin: A Case-Control Study
od: Aseel Hadi Abdulameer, i wsp.
Wydane: (2017-03-01)

ANTITHROMBOTIC THERAPY SAFETY MONITORING BASED ON SPONTANEOUS REPORTS
od: O. V. Shatalova, i wsp.
Wydane: (2015-09-01)

ANTITHROMBOTIC THERAPY SAFETY MONITORING BASED ON SPONTANEOUS REPORTS
od: O. V. Shatalova, i wsp.
Wydane: (2015-09-01)

Idiosyncratic Liver Injury due to Rivaroxaban
od: Aneesh Cherakulam Ratheendran, i wsp.
Wydane: (2017-12-01)

Risks of oral anticoagulants: Analysis of adverse drug reactions reported to the Portuguese National Pharmacovigilance System
od: Ana Sofia Martins, i wsp.
Wydane: (2024-10-01)

Profile and outcome of patients with Warfarin Toxicity admitted in a tertiary care hospital in Bhutan: a cross-sectional study investigators and institutions
od: Yeshey Penjore, i wsp.
Wydane: (2023-05-01)

Massive spontaneous subconjunctival hemorrhage in a patient on therapeutic warfarin: A case report
od: Andrew M. Philip, i wsp.
Wydane: (2021-06-01)

Farmacovigilância: um instrumento necessário
od: Helena Lutéscia Coêlho

Bleeding complications following intramuscular injections among hospitalized anticoagulated patients: a retrospective observational comparative study
od: Marina Davidov, i wsp.
Wydane: (2024-10-01)

Apixaban dosing in hemodialysis - can drug level monitoring mitigate controversies?
od: Simeon Schietzel, i wsp.
Wydane: (2024-10-01)

Assessment of prescribing pattern and adverse drug reaction in patients receiving anticoagulant therapy: A prospective observational study
od: Thangavel Mahalingam Vijayakumar, i wsp.
Wydane: (2023-08-01)

Oral anticoagulants and concurrent rifampin administration in tuberculosis patients with non-valvular atrial fibrillation
od: Ki Won Hwang, i wsp.
Wydane: (2023-04-01)

Bleeding Risk Related to Upper Gastrointestinal Endoscopic Biopsy in Patients Receiving Antithrombotic Therapy: A Multicenter Prospective Observational Study
od: Takafumi Yuki, MD, PhD, i wsp.
Wydane: (2017-01-01)

Interaction between Levothyroxine and Phenprocoumon: a case report
od: Gaeti Walderez, i wsp.
Wydane: (2014-04-01)

Levofloxacin: Analysis of Information on Adverse Reactions from Russian Spontaneous Report Database
od: S. K. Zyryanov, i wsp.
Wydane: (2020-05-01)

Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Frail Patients With Nonvalvular Atrial Fibrillation
od: Brandon K. Martinez, i wsp.
Wydane: (2018-04-01)

Rivaroxaban plasma levels in patients admitted for bleeding events: insights from a prospective study
od: Anne-Laure Sennesael, i wsp.
Wydane: (2018-11-01)

Advancing anticoagulation stewardship: A call to action for stewardship from the US-based anticoagulation forum
od: Allison Burnett, i wsp.
Wydane: (2022-12-01)

Potential drug-drug interactions among patients with spontaneous intracerebral hemorrhage treated at the Neurological Intensive Care Unit: a single-center experience
od: Dejan Z. Aleksić, i wsp.
Wydane: (2022-11-01)

Analysis of spontaneous reporting of suspected adverse drug reactions for non-analgesic over-the-counter drugs from 2008 to 2017
od: Josipa Bukic, i wsp.
Wydane: (2019-10-01)

Improved drug safety through intensive pharmacovigilance in hospitalized pediatric patients
od: Alan O. Vázquez-Alvarez, i wsp.
Wydane: (2017-12-01)

Investigation of possible prophylactic, renoprotective, and cardioprotective effects of thromboprophylactic drugs against ischemia–reperfusion injury
od: Sinan Demirtas, i wsp.
Wydane: (2015-03-01)